Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HepaRAS Trial: Changes in Hepatectomy Risk Assessment When Incorporating Mebrofenin HIDA for Functional Evaluation of the Liver Remnant: A Pilot Study

NCT05280990 is registered in ClinicalTrials.gov with Boris Gala Lopez as lead sponsor.

NCT NCT05280990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05280990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HepaRAS Trial: Changes in Hepatectomy Risk Assessment When Incorporating Mebrofenin HIDA for Functional Evaluation of the Liver Remnant: A Pilot Study
Lead sponsor
Boris Gala Lopez
Phase
Not applicable
Overall status
Withdrawn
Start date
January 15, 2023
Completion date
July 30, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

30-day mortality, liver failure as a complication of care